Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2020 | 1 |
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
4 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Non-coding RNA and immune-checkpoint inhibitors: friends or foes?
Immunotherapy. 2020 May;12(7):513-529. doi: 10.2217/imt-2019-0204. Epub 2020 May 7.
Immunotherapy. 2020.
PMID: 32378480
Review.
Where Do We Stand with Immunotherapy for Advanced Pancreatic Ductal Adenocarcinoma: A Synopsis of Clinical Outcomes.
Akhuba L, Tigai Z, Shek D.
Akhuba L, et al.
Biomedicines. 2022 Dec 9;10(12):3196. doi: 10.3390/biomedicines10123196.
Biomedicines. 2022.
PMID: 36551952
Free PMC article.
Review.
Item in Clipboard
Immune-Checkpoint Inhibitors for Metastatic Colorectal Cancer: A Systematic Review of Clinical Outcomes.
Shek D, Akhuba L, Carlino MS, Nagrial A, Moujaber T, Read SA, Gao B, Ahlenstiel G.
Shek D, et al. Among authors: akhuba l.
Cancers (Basel). 2021 Aug 27;13(17):4345. doi: 10.3390/cancers13174345.
Cancers (Basel). 2021.
PMID: 34503155
Free PMC article.
Review.
Item in Clipboard
Major hurdles of immune-checkpoint inhibitors in pancreatic ductal adenocarcinoma.
Akhuba L, Tigai Z, Shek D.
Akhuba L, et al.
Cancer Drug Resist. 2023 May 30;6(2):327-331. doi: 10.20517/cdr.2022.142. eCollection 2023.
Cancer Drug Resist. 2023.
PMID: 37457121
Free PMC article.
Item in Clipboard
Cite
Cite